ST Pharm breaks ground on 2nd State-of-the-Art Oligonucleotide Facility

Contributed by: PR Newswire

Tags

ST-Pharm-Co

More Like This

SK pharmteco Invests $260 Million to Expand Global Small Molecule and Peptide Production

PR Newswire associated0

Tsingke Biotech Hosts Shanghai Salon on Oligonucleotide Drugs, Spotlighting Next-Gen RNA Therapeutics

PR Newswire associated0

Tsingke Biotech Hosts 2025 Small Nucleic Acid Therapeutics Roundtable in Beijing

SK pharmteco Marks Construction Progress with Ribbon Cutting for Two Advanced Manufacturing Facilities at Swords, Ireland Campus

PR Newswire associated0

Tsingke Biotech Participates in TIDES USA 2025, Demonstrates Full-Scale Oligonucleotide Synthesis Capabilities

SK pharmteco Boosts Domestic Peptide Scale-Up with Investment in California Facility

SK pharmteco Announces CGMP Qualification of its Commercial-Scale Viral Vector Manufacturing Facility in France

TriLink BioTechnologies® Cuts Ribbon on New San Diego Facility for Late Phase mRNA Drug Substance Production (Photo: TriLink BioTechnologies®)

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production